Search

everythinglearnresearchcommunity

for

Search:↓

Research 10 of 1000+

1. 570 Examining cutaneous disease activity as an outcome measure for clinical trials in dermatomyositis Journal of Investigative Dermatology · 2018
2. Evaluation of disease activity and damage in different subtypes of cutaneous lupus erythematosus using the CLASI Journal of the European Academy of Dermatology and Venereology · 2010 · 19 citations
3. All Subcomponents of the Cutaneous Lupus Erythematosus Disease Area and Severity Index–Activity (CLASI-A) are Relevant to Identify and Detect Changes in Skin Activity SKIN The Journal of Cutaneous Medicine · 2026
4. Rosmarinus officinalis and Skin: Antioxidant Activity and Possible Therapeutical Role in Cutaneous Diseases Antioxidants · 2023 · 7 citations
5. Serum IFNα as a Biomarker for Cutaneous Lupus: Insights into Disease Activity, Severity, Therapeutic Monitoring and Clinical Trial Application Journal of Investigative Dermatology · 2025
6. Outcome Measures in Cutaneous Autoimmune Disease: Dermatomyositis and Lupus Erythematosus Technical report · 2006 · 2 citations
7. 341 A longitudinal study of cutaneous dermatomyositis Journal of Investigative Dermatology · 2017
8. Calreticulin: non‐endoplasmic reticulum functions in physiology and disease The FASEB Journal · 2009 · 341 citations
9. Validation of the Cutaneous Lupus Disease Area and Severity Index (CLASI) using physician- and patient-assessed health outcome measures Journal of the American Academy of Dermatology · 2012 · 40 citations
10. Overview of common, rare and atypical manifestations of cutaneous lupus erythematosus and histopathological correlates Lupus · 2010 · 157 citations

Community

— no results